Nucleated Red Blood Cells in ICU Patients and Mortality Risk
Author Information
Author(s): Axel Stachon, Elmar Segbers, Tim Holland-Letz, Reiner Kempf, Steffen Hering, Michael Krieg
Primary Institution: Ruhr-University Bochum
Hypothesis
Does the presence of nucleated red blood cells (NRBCs) in the blood of medical intensive care patients indicate an increased risk of mortality?
Conclusion
The detection of nucleated red blood cells in blood is a strong predictor of increased mortality in critically ill patients.
Supporting Evidence
- The incidence of NRBCs in medical intensive care patients was 17.5%.
- Mortality of NRBC-positive patients was 50.7%, significantly higher than NRBC-negative patients at 9.8%.
- Mortality increased with higher NRBC concentrations, with 78.6% of patients with more than 200/μl dying.
Takeaway
If doctors find special red blood cells in a patient's blood, it means the patient is very sick and might not survive. Checking for these cells every day can help doctors know who needs extra care.
Methodology
A prospective cohort study monitoring nucleated red blood cells in the blood of 383 medical intensive care patients daily.
Potential Biases
Potential bias due to the single-center design and exclusion criteria.
Limitations
The study only included patients from one hospital and excluded those under 18 or post-surgery.
Participant Demographics
Mean age of participants was 66.3 years, with 58.7% male and 41.3% female.
Statistical Information
P-Value
p < 0.001
Confidence Interval
1.987 (1.211–3.261)
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website